Abiopharma

🔍 Ramirez-Medina Lydia Ann (Executive)

Company: FIVE STAR BANCORP (FSBC)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Sold 400 shares of Common Stock at $40.99 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,960.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes 4,332 shares granted pursuant to the Five Star Bancorp 2021 Equity Incentive Plan (including 3,465 shares which have vested and 867 which are scheduled to vest in equal installments over the remainder of a five-year period, provided Ms. Ramirez remains employed by Five Star Bancorp on the respective vesting dates), 6,000 shares granted pursuant to the Five Star Bancorp 2021 Equity Incentive Plan (including 2,400 shares which have vested and 3,600 which are scheduled to vest in equal installments over the remainder of a five-year period, provided Ms. Ramirez remains employed by Five Star Bancorp on the respective vesting dates), and 3,629 shares granted pursuant to the Five Star Bancorp 2021 Equity Incentive Plan (including 726 shares which have vested and 2,903 which are scheduled to vest in equal installments over the remainder of a five-year period, provided Ms. Ramirez remains employed by Five Star Bancorp on the respective vesting dates).